Baird Medical Investment Holdings Limited EBIT

Baird Medical Investment Holdings Limited posts a EBIT of $-10M as of December 2025. That is above the sector sector average of $-26M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a EBIT near $-26M is typical. Baird Medical Investment Holdings Limited's $-10M is higher that level. That is roughly 60.2% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Baird Medical Investment Holdings Limited's financial statement story. At $-10M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BDMD's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $-26M), and (3) consistency with growth and profitability. This page covers the first two; Baird Medical Investment Holdings Limited's other metric pages and overview cover the third.